Target Trials: Generating High-Quality Evidence from Real-World Data @NUFeinbergMed
Target Trials: Generating High-Quality Evidence from Real-World Data  @NUFeinbergMed
Uploaded September 2024 | Updated September 2026, 22 hours ago
Randomized clinical trials have dominated the top of the research evidence pyramid for years. However, in June 2024, JAMA issued a statement endorsing causal inference from observational studies. In this talk, we will 1) review foundational assumptions in causal inference; 2) discuss common pitfalls of analyses of observational data; and 3) review recent advances in causal inference – namely the development of the “target trial” framework – that can provide more confidence in results from these studies.

Featuring:
Lucia C Petito, PhD
Assistant Professor, Preventive Medicine (Biostatistics and Informatics)
Northwestern University
Feinberg School of Medicine
Target Trials: Generating High-Quality Evidence from Real-World DataInside the Human Longevity LaboratoryTurning Psychology into Population Mental Health Science: The Case of Early Child DevelopmentWhat are adaptogens? An evidence-based guide on stress and supplements.How AI is Improving Healthcare Delivery with Mozzi Etemadi, MD, PhDUmbilical Cord Blood Biomarkers May Improve Preterm Infant CareBody’s Own Cannabinoids May Be Key to Reducing Excessive Fear ResponsesFeinberg at a GlanceHealth Economics in an Inequitable World: Cardiovascular Medicine as a Case StudyInside Northwestern’s Collaborative Research EcosystemWhy I Chose My Specialty: Interventional RadiologyReducing Barriers To Health Equity: The Interface of Public Health and Academic Medical Institutions
Northwestern Univ. Feinberg School of Medicine |

Target Trials: Generating High-Quality Evidence from Real-World Data

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER